In addition to this both murine and human studies have shown that the loss of TET2 does not result in leukaemic transformation but does lead to preleukaemic states such as MDS through activation of downstream genes associated with self-renewal and cellular growth [47]. This evidence concerns the gene TET2 and myelodysplastic syndrome.